MARIPOSA THERAPEUTICS LIMITED
Research and experimental development on biotechnology
MARIPOSA THERAPEUTICS LIMITED
Research and experimental development on biotechnology
Contact & Details
Contact
Registered Address
International House 10 Churchill Way Cardiff CF10 2HE Wales
Full company profile for MARIPOSA THERAPEUTICS LIMITED (12373627), an active life sciences and medical technology company based in Cardiff, Wales. Incorporated 20 Dec 2019. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2020–2024)
Cash in Bank
£3.81k
Net Assets
£1.46M
Total Liabilities
£297.50k
Turnover
N/A
Employees
4
Debt Ratio
17%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 Dec Year End | 2023 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
Investors (2)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 1 | Aug 2020 | Pre-Seed |
| Investor 2 | Aug 2020 | Pre-Seed |
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Catharina Hendrika Gezina Maria Beumer | Director | Dutch | United Kingdom | 20 Dec 2019 | Active |
| Catharina Hendrika Gezina Maria Beumer | Secretary | Unknown | Unknown | 20 Dec 2019 | Active |
| William Pigg | Director | British | England | 12 Mar 2021 | Active |
See all 5 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (3)
Mr Lucas Maximilian Hafner
Dutch
- Ownership Of Shares 25 To 50 Percent
- Voting Rights 25 To 50 Percent
- Right To Appoint And Remove Directors
Mr Timothy Calvin Hafner
Dutch
- Ownership Of Shares 25 To 50 Percent
- Voting Rights 25 To 50 Percent
- Right To Appoint And Remove Directors
Ctl Familienstiftung
Unknown
- Ownership Of Shares 75 To 100 Percent As Trust,voting Rights 75 To 100 Percent As Trust,right To Appoint And Remove Directors As Trust
Neem Biotech Limited
Ceased 28 Jul 2022
Group Structure
Group Structure
No group structure identified
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 29 Jan 2026 | Persons With Significant Control | Cessation of Ctl Familienstiftung as a person with significant control on 29 Jan 2026 | |
| 29 Jan 2026 | Persons With Significant Control | Timothy Calvin Hafner notified as a person with significant control | |
| 29 Jan 2026 | Confirmation Statement | Confirmation statement made on 29 Jan 2026 with updates | |
| 29 Jan 2026 | Persons With Significant Control | Lucas Maximilian Hafner notified as a person with significant control | |
| 26 Sept 2025 | Officers | Change to director Thomas Christian Hafner on 1 Sept 2025 |
Cessation of Ctl Familienstiftung as a person with significant control on 29 Jan 2026
Timothy Calvin Hafner notified as a person with significant control
Confirmation statement made on 29 Jan 2026 with updates
Lucas Maximilian Hafner notified as a person with significant control
Change to director Thomas Christian Hafner on 1 Sept 2025
Recent Activity
Latest Activity
Cessation of Ctl Familienstiftung as a person with significant control on 29 Jan 2026
2 months ago on 29 Jan 2026
Timothy Calvin Hafner notified as a person with significant control
2 months ago on 29 Jan 2026
Confirmation statement made on 29 Jan 2026 with updates
2 months ago on 29 Jan 2026
Lucas Maximilian Hafner notified as a person with significant control
2 months ago on 29 Jan 2026
Change to director Thomas Christian Hafner on 1 Sept 2025
7 months ago on 26 Sept 2025